vimarsana.com

Latest Breaking News On - Aurinia pharmaceuticals trading down - Page 1 : vimarsana.com

Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 52-Week Low Following Weak Earnings

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) shares reached a new 52-week low during trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $5.50 and last traded at $5.91, with a volume of 6703556 shares traded. The stock had previously closed at $7.97. The […]

Aurinia Pharmaceuticals (AUPH) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a research note released on Friday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals in a report on Thursday, August 17th. […]

Aurinia Pharmaceuticals (TSE:AUP) Shares Down 3 5%

Aurinia Pharmaceuticals Inc. (TSE:AUP – Get Free Report) (NASDAQ:AUPH) shares fell 3.5% during mid-day trading on Monday . The stock traded as low as C$16.41 and last traded at C$16.76. 4,611,683 shares traded hands during trading, an increase of 1,906% from the average session volume of 229,895 shares. The stock had previously closed at C$17.37. […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Now Covered by Analysts at StockNews com

StockNews.com initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently commented on the company. Royal Bank of Canada upped their price objective on Aurinia Pharmaceuticals from $11.00 to […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.